Long-term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetes.

Date publication

décembre 2005

Auteurs

Membres identifiés du Cancéropôle Est :
Pr VERGES Bruno

Tous les auteurs :
Betteridge DJ, Verges B

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/16283239

Résumé

Aims/hypothesis: The aim of this study was to determine the long-term effects of pioglitazone add-on to metformin or sulphonylurea on plasma lipids and lipoproteins. Materials and methods: The effects of pioglitazone were studied in two clinical trials in patients with inadequately controlled type 2 diabetes (HbA(1)c >= 7.5 and

Référence

Diabetologia. 2005 Dec;48(12):2477-81